AP Biosciences doses first patient in phase 1 clinical study to evaluate AP402 for HER2+ cancer patients: Taipei City, Taiwan Thursday, April 24, 2025, 18:00 Hrs [IST] AP Bioscien ...

Gujarat FDCA exposes interstate distribution of counterfeit drugs using fake QR codes: Shardul Nautiyal, Mumbai Thursday, ...

Clarivate introduces DRG Commercial Analytics 360 enabling medtech companies to advance commercial strategy and execution: London, UK Thursday, April 24, 2025, 17:00 Hrs [IST] Cla ...

Medical experts state India’s malaria-free status faces misdiagnosis, treatment delays & neglected urban infrastructure: Our Bureau, Bengaluru Thursday, April 24, 2025, 16:45 Hr ...

Akums and Tamil Nadu Agricultural University announce strategic partnership for pharmaceutical innovation: Our Bureau, Bengaluru Thursday, April 24, 2025, 15:40 Hrs [IST] Akums Dr ...

DKSH establishes climate partnership with Klimate for CO2 removals: Zurich, Switzerland Thursday, April 24, 2025, 15:15 Hrs [IST] DKSH has signed a CO2 removal purchase agreement ...

Boehringer Ingelheim & Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers: Ingelheim, Germany Thursday, April 24, 2025, 15 ...

Our Bureau, Mumbai Thursday, April 24, 2025, 14:20 Hrs [IST] ...

Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore: Our Bureau, Bengaluru Thursday, April 24, 2025 ...

Molbio Diagnostics increases cervical cancer screening for Indian women with upgraded Truenat HPV-HR Plus: Our Bureau, Bengaluru Thursday, April 24, 2025, 14:45 Hrs [IST] Molbio D ...

Menlo Park, California Thursday, April 24, 2025, 13:00 Hrs [IST] ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for tolvaptan ...